Everyone is About to Become Lean and Muscly (new evidence) — Transcript
Full transcript
- 0:00In 2024, a baby was born in Germany who
- 0:02by any measure was impossible. He was
- 0:04only a few days old and he already had
- 0:06visible muscles. His thighs and upper
- 0:08arms looked like a tiny bodybuilder.
- 0:11Doctors checked him for every disease
- 0:12that could explain it and they found
- 0:14nothing wrong. He wasn't sick. He was
- 0:16just extraordinarily, effortlessly
- 0:18strong. And when they looked at his
- 0:20genes, they found the answer. He'd been
- 0:22born with both copies of a single gene
- 0:24switched off. A gene that makes a
- 0:26protein called myostatin and myostatin,
- 0:29it turns out, has one job in your body
- 0:31to put the brakes on muscle growth. It's
- 0:33one of the reasons why you don't just
- 0:35keep adding on muscle forever. The
- 0:36baby's brakes were just gone and
- 0:38scientists that only found the myostatin
- 0:40gene about 7 years earlier in 1997. And
- 0:44the moment they understood what it did,
- 0:45the implications were staggering. If you
- 0:47could switch off the myostatin gene in
- 0:49anyone on purpose, you might be able to
- 0:52beat diseases that waste muscle away
- 0:54like muscular dystrophy or even
- 0:56sarcopenia. There was just one problem.
- 0:58For nearly 30 years, nobody could switch
- 1:00off the myostatin gene safely. But the
- 1:03breakthrough, which has only just been
- 1:04published, arrived in time to address a
- 1:06growing problem that didn't even exist
- 1:08in 1997. The problem is an unintended
- 1:11consequence of what's happened to weight
- 1:13loss over the past few years. So we have
- 1:15become incredibly, astonishingly good at
- 1:18melting fat away. So a decade ago, the
- 1:20best drugs took about 8% of your body
- 1:22weight off and with the burden of daily
- 1:24injections, most people just gave up.
- 1:26But then came semaglutide or Ozempic
- 1:29that increased weight loss to around %
- 1:32then to zepbound pushed it past 20% and
- 1:34the newest one in the line, a triple
- 1:36agonist drug called retatrutide, it took
- 1:38people down by 28% of their body weight
- 1:41loss in a big recent trial. So for
- 1:43someone starting at about 110 kg, that's
- 1:46more than 30 kg gone from a weekly
- 1:49injection. That's bariatric surgery
- 1:51territory, of course, without the
- 1:52surgery. But here's the catch and it's
- 1:54all over the internet right now. When
- 1:56you lose that much weight, some of what
- 1:58you lose is not fat. It's muscle, and
- 2:00you've probably seen what that can look
- 2:02like. If someone drops a huge amount of
- 2:04weight, they end up looking smaller, but
- 2:05they can also look a bit hollowed out
- 2:07and gaunt. So, some people started to
- 2:09panic that these drugs were melting
- 2:10people's muscle away. But, we do need
- 2:12some critical context here because the
- 2:14truth is far more boring and reassuring
- 2:16than the panic. So, when researchers
- 2:18pulled 22 trials of these drugs and
- 2:20added up exactly where that weight loss
- 2:22actually came from, about a quarter of
- 2:24it was muscle, and three quarters of it
- 2:26was fat. But, here's what most people
- 2:28miss. That 25% lean mass loss is not
- 2:31unique to Ozempic or other GLP-1
- 2:33medications. A quarter is roughly what
- 2:35you'd lose when you diet the
- 2:37old-fashioned way. It's roughly what you
- 2:39lose after weight loss surgery. Doctors
- 2:41have a decades-old rule of thumb that
- 2:42about a quarter of any weight that you
- 2:44lose is in lean tissue. Now, we can
- 2:47counteract some of this muscle mass loss
- 2:49by a good protein diet and regular
- 2:50resistance exercise. But, the dream
- 2:52result is that we only want to lose fat
- 2:55mass, not lean mass. We want to protect
- 2:57our muscles during this weight loss
- 2:58journey, and the key to that holy grail
- 3:00of losing fat and not muscle brings us
- 3:03to myostatin. In 1997, researchers bred
- 3:06mice with the myostatin gene deleted,
- 3:08and the mice, they grew enormous. They
- 3:09look exactly like the double-muscled
- 3:12cattle that farmers had bred for
- 3:13centuries. They were bulging, blocky,
- 3:15with twice the muscles of a normal mouse
- 3:17from a single gene switched off. So, the
- 3:20dream here is obvious. If turning off
- 3:22the myostatin gene doubles muscle mass
- 3:24in a mouse, then a drug that turns it
- 3:26off in a person could rebuild the wasted
- 3:29muscles of dystrophy or of old age. And
- 3:32then in 2004, proof that it might be
- 3:34safe in humans came from that German
- 3:36baby. It was an example of a natural
- 3:38human myostatin knockout walking around
- 3:41who was extraordinarily strong and
- 3:43completely healthy. If we managed to
- 3:44turn this gene off, it seemed, then
- 3:46nothing appeared to break. So, the
- 3:48target was obvious, and the safety
- 3:49looked reassuring, and the prize was
- 3:52enormous. And then for nearly 30 years,
- 3:54almost everyone who tried to hit this
- 3:56target failed. But why? Well, the tool
- 3:58that you'd use is a monoclonal antibody.
- 4:01Think of it like a guided missile that
- 4:03scientists designed to lock in onto one
- 4:04specific molecule shape and then
- 4:06neutralize it. The problem is that when
- 4:08myostatin is switched on, it looks
- 4:10almost identical to a whole family of
- 4:12related proteins that your body needs
- 4:14for other jobs. So, the missile aimed at
- 4:16active myostatin, it tends to hit its
- 4:19other cousins, too. And that's when you
- 4:20get side effects, or you blunt things
- 4:22that you never meant to touch. So, after
- 4:24decades of attempts, the verdict in the
- 4:26field became almost a punchline. Great
- 4:28expectations, but with limited success.
- 4:30So, the breakthrough was about being
- 4:31more precise. So, the newest drug,
- 4:34called apitegromab, it doesn't go after
- 4:36active myostatin, where all the
- 4:38look-alike cousins are. Instead, it
- 4:40grabs the myostatin earlier in its
- 4:42inactive, folded-up precursor form,
- 4:44before it's ever switched on. And that
- 4:46precursor shape is far more unique.
- 4:48Nothing else in the family looks quite
- 4:50like it. So, the missile finally locks
- 4:52on to myostatin and only myostatin, and
- 4:55it leaves everything else alone. That
- 4:57selectivity, as in hitting one target
- 4:59cleanly, is the exact thing that 30
- 5:01years of attempts have been missing. And
- 5:03before anyone ever pointed the strike at
- 5:05weight loss, it earned its stripes
- 5:07somewhere far more demanding.
- 5:09Apitegromab, it was first tested in
- 5:11spinal muscular atrophy, a brutal
- 5:13genetic disease that destroys muscles of
- 5:15children. In trials there, it improved
- 5:18motor function in kids who were losing
- 5:19it. And it did so safely. So, the tool
- 5:22had finally matured. We finally had a
- 5:24clean, selective, human-proven way to
- 5:26take the break off muscle formation. And
- 5:29it matured at the exact moment that the
- 5:30world handed it a brand new use. Because
- 5:33just as apitegromab was proving itself,
- 5:35the new weight loss drugs, they were
- 5:36driving fat loss faster than medicine
- 5:39had ever seen. So, does this approach
- 5:41work by combining GLP-1 medications, or
- 5:43the weight loss medications, with
- 5:45myostatin inhibitors? Well, yes, but
- 5:47there are problems. So, there were two
- 5:49medications that were leading the race
- 5:51to apply this breakthrough in muscle
- 5:53preservation to the problem of muscle
- 5:55loss during weight loss. So, they
- 5:56represent two completely different
- 5:58philosophies on how aggressive you
- 5:59should be. So, the first one we've
- 6:01already talked about, a pigaveramab,
- 6:03it's the clean one. It does exactly what
- 6:05we just described. It selectively blocks
- 6:07myostatin, but it's bimagrumab that's
- 6:10the showstopper. And instead of just
- 6:11blocking myostatin, it blocks a broader
- 6:14docking port, the active receptor, which
- 6:16is a much heavier hand on the whole
- 6:18system. And on its own, it does
- 6:19something that no diet drug does. So,
- 6:21people's muscles actually grew as their
- 6:24fat fell, though the total weight loss
- 6:26was modest. So, if you bolt it onto
- 6:27semaglutide, you get the headline
- 6:29number, substantial weight loss, about
- 6:3192% of it from fat, with muscle largely
- 6:34protected. So, the muscle mass loss is
- 6:36much smaller here compared to
- 6:38semaglutide alone. And it's genuinely
- 6:40the closest thing that anyone has made
- 6:42to the lean and ripped from a vial. But
- 6:44that power comes with serious downsides.
- 6:46Most people on bimagrumab, they got
- 6:48muscle spasms. About a third of them got
- 6:50acne, and more seriously, it pushed up
- 6:53their LDL cholesterol, the kind that can
- 6:55build up in blood vessels, by as much as
- 6:5717%. So, that is the wrong direction for
- 7:00your heart. And then quietly, in
- 7:01September 2025, the company developing
- 7:04one of the big bimagrumab combinations
- 7:07paused their program because of these
- 7:08safety signals. All of this creates a
- 7:10lingering worry that if we start using
- 7:12these drugs to protect our muscles,
- 7:14maybe they start creating problems with
- 7:16our hearts. But if you can push gently,
- 7:18maybe that's when you can spare the
- 7:20muscles cleanly and not have any of
- 7:22these side effects, which is exactly why
- 7:24the gentle clean drugs, or the a
- 7:25pigaveramab, matters so much. The whole
- 7:28bit is that you can protect your muscles
- 7:30without poking the heart. So, does it
- 7:32work? Well, this is the trial that
- 7:33inspired this video. It's called
- 7:35Embrace, and the design is beautifully
- 7:38simple. So, they took 102 adults with
- 7:40obesity, and every single one of them
- 7:42were put onto Zepbound, and then they
- 7:44split them into two groups. So, one half
- 7:46also got the apitegromab, the muscle
- 7:48protector, and the other half got a
- 7:50dummy infusion on top. Neither patients
- 7:52nor the doctors knew who got which.
- 7:54After 6 months, they measured everyone
- 7:56and measured precisely how much of the
- 7:58weight that was lost was from fat and
- 8:00how much was from lean mass. And the
- 8:02combination appeared to work. So, the
- 8:04group on the apitegromab, they lost
- 8:06about half as much lean mass compared to
- 8:09the placebo group. Both groups lost
- 8:11about the same amount of weight, but in
- 8:12the apitegromab group, a far bigger
- 8:14share of that weight was fat, about 85%
- 8:17fat versus 70% in the placebo group. So,
- 8:20this gives us the first hint that we
- 8:22might hit the holy grail in the future
- 8:24where we can lose fat mass and also
- 8:26protect our lean mass, where we can get
- 8:28the best of both worlds and do it
- 8:30safely. But, we also need to be clear
- 8:31about what the study found because
- 8:33there's a key result that the headlines
- 8:35skipped. So, the apitegromab group, they
- 8:37were not measurably stronger. The trial
- 8:39tested it directly. So, they used grip
- 8:41strength and how easily people could
- 8:43stand up and then sit back down in a
- 8:44chair. So, on both measures, the muscle
- 8:47protected group were no better than the
- 8:49dummy injection group. The drug kept the
- 8:51muscle on the scan, but that extra
- 8:52muscle, it didn't let people do anything
- 8:54more with their bodies. And those are
- 8:56two different things. Keeping lean mass
- 8:58that shows up on a scan is the means,
- 9:00but being stronger and more capable and
- 9:02less frail, that's actually the goal.
- 9:04And only the first one was proven here.
- 9:06Instead, this trial represents again
- 9:07where the future is potentially headed
- 9:09where we can all be a healthy weight and
- 9:11still have strong muscles no matter our
- 9:13age, but more work is needed. And a few
- 9:16blunt words on what the internet will
- 9:17try and sell you here. So, if you search
- 9:19how to keep muscle on Ozempic, you'll
- 9:21likely fall into a world of gray market
- 9:23scams and muscle peptides with names
- 9:26like YK11 for protecting muscle during
- 9:28weight loss. These essentially have no
- 9:30proper human evidence in the form of
- 9:32well-designed and conducted randomized
- 9:34controlled trials. What they have
- 9:35instead is a real track record of liver
- 9:37damage and even worse. So, in my
- 9:39opinion, they're not worth your money
- 9:41and not worth your liver's health.
- 9:42Instead, here's what to actually do
- 9:44about muscle loss while you're on GLP-1
- 9:46medications today. So, the thing that
- 9:48works right now with no prescription and
- 9:50no risk is the unglamorous one,
- 9:52resistance training a couple of times a
- 9:54week and enough protein in your diet.
- 9:56That is the part that you can control
- 9:58and it already works. For me personally,
- 10:00I take 1.25 mg of tirzepatide a week
- 10:03myself and I protect my muscles by doing
- 10:05exactly this, by doing resistance
- 10:07exercise and eating enough protein. And
- 10:09one supplement worth considering is
- 10:11creatine. It's the most studied
- 10:12ingredient there is for muscle and
- 10:14strength. And one last thing, I just
- 10:16mentioned that I take tirzepatide, not
- 10:18the newer and more powerful retatrutide.
- 10:20And there's a very good reason for this.
- 10:22And there's also a good reason why I
- 10:23take one of these medications even
- 10:25though I'm lean and non-diabetic. So,
- 10:27make sure to check out this next video
- 10:29here where I lay out all of my
- 10:30reasoning.
About this transcript
This page contains the full transcript of Everyone is About to Become Lean and Muscly (new evidence) by Dr Brad Stanfield, generated from the public captions YouTube serves with the video. The transcript has 2,089 words across 311 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.
What you can do with it
Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to translate the transcript into 100+ languages.
Free YouTube transcript tool
YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, translation to 100+ languages, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.